Pictet Asset Management (UK)’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $62.1M | Buy |
1,601,224
+559,953
| +54% | +$21.7M | 0.07% | 304 |
|
|
2021
Q1 | $50.2M | Buy |
1,041,271
+300,935
| +41% | +$14.5M | 0.06% | 326 |
|
|
2020
Q4 | $38.5M | Buy |
740,336
+732,536
| +9,391% | +$38.1M | 0.05% | 355 |
|
|
2020
Q3 | $209K | Buy |
+7,800
| New | +$209K | ﹤0.01% | 1396 |
|
|
2016
Q3 | – | Sell |
-1,215,449
| Closed | -$9.14M | – | 851 |
|
|
2016
Q2 | $9.14M | Buy |
1,215,449
+1,073,049
| +754% | +$8.07M | 0.04% | 447 |
|
|
2016
Q1 | $1.19M | Hold |
142,400
| – | – | 0.01% | 747 |
|
|
2015
Q4 | $1.7M | Buy |
142,400
+1,700
| +1% | +$20.3K | 0.01% | 743 |
|
|
2015
Q3 | $1.42M | Buy |
140,700
+71,300
| +103% | +$719K | 0.01% | 756 |
|
|
2015
Q2 | $1.21M | Buy |
69,400
+20,100
| +41% | +$351K | ﹤0.01% | 786 |
|
|
2015
Q1 | $688K | Buy |
+49,300
| New | +$688K | ﹤0.01% | 819 |
|